Abstract
Advanced heart failure (ACC/AHA stage D) affects about 10% of all patients with heart failure secondary to systolic dysfunction, and is defined by persistent symptoms and disease progression despite optimal medical and device therapy. This group of patients has a mortality rate that approaches 50% at 6 months. Heart transplantation, the best currently available solution for the appropriate patient, is unfortunately limited by donor availability. This chapter discusses alternative device therapy for patients with advanced heart failure, including ventricular assist devices and total artificial hearts.
Key Words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hunt, S.A., et al., ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation, 2001. 104(24):2996–3007.
Stevenson, L.W. and R.L. Kormos, Mechanical Cardiac Support 2000: Current applications and future trial design. J Thorac Cardiovasc Surg, 2001. 121(3):418–24.
Vitali, E., et al., Different clinical scenarios for circulatory mechanical support in acute and chronic heart failure. Am J Cardiol, 2005. 96(12A):34L–41L.
Moulopoulos, S.D., S.R. Topaz, and W.J. Kolff, Extracorporeal assistance to the circulation and intraaortic balloon pumping. Trans Am Soc Artif Intern Organs, 1962. 8:85–9.
Kantrowitz, A., et al., Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA, 1968. 203(2):113–8.
Allen, G.S., K.D. Murray, and D.B. Olsen, The importance of pulsatile and nonpulsatile flow in the design of blood pumps. Artif Organs, 1997. 21(8):922–8.
Song, X., et al., Axial flow blood pumps. Asaio J, 2003. 49(4):355–64.
Mudge, G.H., Jr., The management of mechanical hearts. Trans Am Clin Climatol Assoc, 2005. 116:283–91; discussion 292.
Pennington, D.G., et al., Long-term follow-up of postcardiotomy patients with profound cardiogenic shock treated with ventricular assist devices. Circulation, 1985. 72(3 Pt 2):II216–26.
Hill, J.D., et al., Bridge to cardiac transplantation: successful use of prosthetic biventricular support in a patient awaiting a donor heart. ASAIO Trans, 1986. 32(1):233–7.
Farrar, D.J., The thoratec ventricular assist device: a paracorporeal pump for treating acute and chronic heart failure. Semin Thorac Cardiovasc Surg, 2000. 12(3):243–50.
Thoratec, Heartmate XVE LVAS: Clinical Operation and Patient Management. 2006.
Rose, E.A., et al., Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation, 1994. 90(5 Pt 2):II87–91.
Slater, J.P., et al., Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg, 1996. 62(5):1321–7; discussion 1328.
Long, J.W., Advanced mechanical circulatory support with the HeartMate left ventricular assist device in the year 2000. Ann Thorac Surg, 2001. 71(3 Suppl):S176–82; discussion S183–4.
Spanier, T., et al., Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. J Thorac Cardiovasc Surg, 1996. 112(4):1090–7.
Spanier, T.B., et al., Time-dependent cellular population of textured-surface left ventricular assist devices contributes to the development of a biphasic systemic procoagulant response. J Thorac Cardiovasc Surg, 1999. 118(3):404–13.
Tayama, E., et al., The DeBakey ventricular assist device: current status in 1997. Artif Organs, 1999. 23(12):1113–6.
Noon, G.P., et al., Development and clinical application of the MicroMed DeBakey VAD. Curr Opin Cardiol, 2000. 15(3):166–71.
Noon, G.P., et al., Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg, 2001. 71(3 Suppl):S133–8; discussion S144–6.
SoRelle, R., First US implantation of DeBakey ventricular assist device. Circulation, 2000. 101(24):E9056–7.
Delgado, R. and M. Bergheim, HeartMate II left ventricular assist device: a new device for advanced heart failure. Expert Rev Med Dev, 2005. 2(5):529–32.
Amir, O., et al., A successful anticoagulation protocol for the first HeartMate II implantation in the United States. Tex Heart Inst J, 2005. 32(3):399–401.
Hoshi, H., T. Shinshi, and S. Takatani, Third-generation blood pumps with mechanical noncontact magnetic bearings. Artif Organs, 2006. 30(5):324–38.
Onuma, H., M. Murakami, and T. Masuzawa, Novel maglev pump with a combined magnetic bearing. Asaio J, 2005. 51(1):50–5.
Gray, N.A., Jr. and C.H. Selzman, Current status of the total artificial heart. Am Heart J, 2006. 152(1):4–10.
Dowling, R.D., et al., The AbioCor implantable replacement heart. Ann Thorac Surg, 2003. 75(6 Suppl):S93–9.
Smith, M.C., et al., CardioWest total artificial heart in a moribund adolescent with left ventricular thrombi. Ann Thorac Surg, 2005. 80(4):1490–2.
El-Banayosy, A., et al., CardioWest total artificial heart: Bad Oeynhausen experience. Ann Thorac Surg, 2005. 80(2):548–52.
DeVries, W.C., et al., Clinical use of the total artificial heart. N Engl J Med, 1984. 310(5):273–8.
Felker, G.M. and J.G. Rogers, Same bridge, new destinations rethinking paradigms for mechanical cardiac support in heart failure. J Am Coll Cardiol, 2006. 47(5):930–2.
Oz, M.C., et al., Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation, 1995. 92(9 Suppl):II169–73.
Deng, M.C., et al., Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation, 2001. 103(2):231–7.
Piccione, W., Jr., Mechanical circulatory assistance: changing indications and options. J Heart Lung Transplant, 1997. 16(6):S25–8.
Nakatani, S., et al., Prediction of right ventricular dysfunction after left ventricular assist device implantation. Circulation, 1996. 94(9 Suppl):II216–21.
Burkhoff, D., et al., Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock. Catheter Cardiovasc Interv, 2006. 68(2):211–7.
Marelli, D., et al., Temporary mechanical support with the BVS 5000 assist device during treatment of acute myocarditis. J Card Surg, 1997. 12(1):55–9.
Guyton, R.A., et al., Postcardiotomy shock: clinical evaluation of the BVS 5000 Biventricular Support System. Ann Thorac Surg, 1993. 56(2):346–56.
Samuels, L.E., et al., Management of acute cardiac failure with mechanical assist: experience with the ABIOMED BVS 5000. Ann Thorac Surg, 2001. 71(3 Suppl):S67–72; discussion S82–5.
Hoefer, D., et al., Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann Thorac Surg, 2006. 82(1):28–33.
Deng, M.C., et al., Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report – 2005. J Heart Lung Transplant, 2005. 24(9):1182–7.
Jaski, B.E., et al., Cardiac transplant outcome of patients supported on left ventricular assist device vs. intravenous inotropic therapy. J Heart Lung Transplant, 2001. 20(4):449–56.
Frazier, O.H., et al., Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg, 1992. 53(6):1080–90.
Frazier, O.H., et al., Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg, 2001. 122(6):1186–95.
Ashton, R.C., Jr., et al., Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant, 1996. 15(11):1151–7.
Aaronson, K.D., et al., Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol, 2002. 39(8):1247–54.
El-Banayosy, A., et al., Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study. J Thorac Cardiovasc Surg, 2000. 119(3):581–7.
Navia, J.L., et al., Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? Ann Thorac Surg, 2002. 74(6):2051–62; discussion 2062–3.
Goldstein, D.J., Worldwide experience with the MicroMed DeBakey ventricular assist device as a bridge to transplantation. Circulation, 2003. 108(Suppl 1):II272–7.
Frazier, O.H., et al., Use of the Jarvik 2000 left ventricular assist system as a bridge to heart transplantation or as destination therapy for patients with chronic heart failure. Ann Surg, 2003. 237(5):631–6; discussion 636–7.
Copeland, J.G., et al., Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med, 2004. 351(9):859–67.
Bruckner, B.A., et al., Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant, 2001. 20(4): 457–64.
Baba, H.A., et al., Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support. J Heart Lung Transplant, 2000. 19(7):668–74.
McCarthy, P.M., et al., Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg, 1995. 59(3):609–13.
Torre-Amione, G., et al., Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: A potential mechanism for cardiac recovery. Circulation, 1999. 100(11):1189–93.
Blaxall, B.C., et al., Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol, 2003. 41(7): 1096–106.
Klotz, S., et al., Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol, 2005. 45(5):668–76.
Simon, M.A., et al., Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation, 2005. 112(9 Suppl):I32–6.
Mancini, D.M., et al., Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation, 1998. 98(22):2383–9.
Khan, T., et al., Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant, 2003. 22(2):137–46.
Dandel, M., et al., Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation, 2005. 112(9 Suppl): I37–45.
Dib, N., et al., Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy. Cell Transplant, 2005. 14(1):11–9.
Rose, E.A., et al., Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med, 2001. 345(20):1435–43.
Park, S.J., et al., Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg, 2005. 129(1):9–17.
Long, J.W., et al., Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail, 2005. 11(3):133–8.
Lietz, K., et al., Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation, 2007. 116(5):497–505.
Stevenson, L.W., et al., Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation, 2004. 110(8):975–81.
Oz, M.C., et al., Left ventricular assist devices as permanent heart failure therapy: the price of progress. Ann Surg, 2003. 238(4):577–83; discussion 583–5.
Miller, L.W., et al., Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. J Heart Lung Transplant, 2006. 25(7):778–84.
McGregor, M., Implantable ventricular assist devices: is it time to introduce them in Canada? Can J Cardiol, 2000. 16(5):629–40.
Clegg, A.J., et al., The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. Health Technol Assess, 2005. 9(45):1–148.
Minami, K., et al., Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor, and HeartMate for bridging to heart transplantation. Artif Organs, 2000. 24(6):421–6.
Holman, W.L., et al., Infection in ventricular assist devices: prevention and treatment. Ann Thorac Surg, 2003. 75(6 Suppl):S48–57.
Padera, R.F., Infection in ventricular assist devices: the role of biofilm. Cardiovasc Pathol, 2006. 15(5):264–70.
Costerton, J.W., L. Montanaro, and C.R. Arciola, Biofilm in implant infections: its production and regulation. Int J Artif Organs, 2005. 28(11):1062–8.
Chinn, R., et al., Multicenter experience: prevention and management of left ventricular assist device infections. Asaio J, 2005. 51(4):461–70.
Itescu, S., et al., Immunobiology of left ventricular assist devices. Prog Cardiovasc Dis, 2000. 43(1):67–80.
Ankersmit, H.J., et al., Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet, 1999. 354(9178): 550–5.
Gonzalez-Stawinski, G.V., et al., Early and midterm risk of coronary allograft vasculopathy in patients bridged to orthotopic heart transplantation with ventricular assist devices. Transplantation, 2005. 79(9):1175–9.
Lazar, R.M., et al., Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation, 2004. 109(20):2423–7.
Goldstein, D.J. and R.B. Beauford, Left ventricular assist devices and bleeding: adding insult to injury. Ann Thorac Surg, 2003. 75(6 Suppl):S42–7.
Horton, S.C., et al., Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol, 2005. 45(9):1435–40.
Horton, S.C., et al., Left ventricular assist device malfunction: a systematic approach to diagnosis. J Am Coll Cardiol, 2004. 43(9):1574–83.
Ruzevich, S.A., et al., Retrospective analysis of the psychologic effects of mechanical circulatory support. J Heart Transplant, 1990. 9(3 Pt 1):209–12.
Dew, M.A., et al., Life quality in the era of bridging to cardiac transplantation. Bridge patients in an outpatient setting. Asaio J, 1993. 39(2):145–52.
Petrucci, R., et al., Cardiac ventricular support. Considerations for psychiatry. Psychosomatics, 1999. 40(4):298–303.
Bunzel, B., et al., Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses. J Heart Lung Transplant, 2007. 26(4):384–9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Blitz, A., Fang, J.C. (2010). Ventricular Assist Devices and Total Artificial Hearts. In: Maisel, W. (eds) Device Therapy in Heart Failure. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-424-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-59745-424-7_13
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-58829-994-9
Online ISBN: 978-1-59745-424-7
eBook Packages: MedicineMedicine (R0)